219 filings
Page 5 of 11
POSASR
ysl6lhq9ezp3af90l9v6
10 Mar 22
Automatic shelf registration (post-effective amendment)
7:14pm
8-K
sobxz
10 Mar 22
BioXcel Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Operational Highlights
8:12am
8-K
hs4fq3uvurzq5ctwhq
13 Jan 22
Results of Operations and Financial Condition
8:08am
8-K
t29ujhy850 xea5mlkkk
2 Dec 21
Other Events
12:00am
8-K
ry9bgmxlq
10 Nov 21
BioXcel Therapeutics Reports Third Quarter 2021 Financial Results and Recent Operational Highlights
7:15am
8-K
wwoob19yxmaxxuscr3c
25 Oct 21
Regulation FD Disclosure
7:01am
8-K
57j06ubce1s
13 Oct 21
Departure of Directors or Certain Officers
5:02pm
8-K
bscishx89 g1jyxcg84
9 Sep 21
Regulation FD Disclosure
5:01pm
8-K
bi8lg690yrb
10 Aug 21
BioXcel Therapeutics Reports Second Quarter 2021 Financial Results and Recent Operational Highlights
7:08am
8-K
ut0pcqdlqaf3ht7u
23 Jul 21
Departure of Directors or Certain Officers
4:45pm
8-K
2ykepu
25 Jun 21
Entry into a Material Definitive Agreement
5:05pm
424B5
91mu4qqunrh v0g
24 Jun 21
Prospectus supplement for primary offering
4:25pm
424B5
j12svssuurav81wqv
22 Jun 21
Prospectus supplement for primary offering
4:06pm
8-K
oxd 12zje38uqp
22 Jun 21
Other Events
4:04pm
8-K
v5ewxx
14 Jun 21
Amendments to Articles of Incorporation or Bylaws
4:12pm
8-K
mk87oh lasn5tjeq4
10 May 21
Entry into a Material Definitive Agreement
4:49pm
424B5
2mtf89myjzkse yu
10 May 21
Prospectus supplement for primary offering
4:45pm